OPEN-LABEL, PROSPECTIVE EXPLORATORY STUDY TO ASSESS THE EFFECTS OF FORMOTEROL AND BECLOMETASONE DIPROPIONATE COMBINATION THERAPY USING A DPI DEVICE ON CENTRAL AND PERIPHERAL AIRWAY DIMENSIONS IN ASTHMATIC PATIENTS.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 16 Aug 2014 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
- 18 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 Sep 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2011-003249-16).